Previously published to Propelo.AI on the future of data and engineering excellence Data is propelling new business. And its impact on the business community has, in a way, become an art form. And the art of understanding business data, or business intelligence (BI), is centered on a company’s ability to read, transform, optimize and present this data between both technical and non-technical teams. As a result, it empowers businesses to improve operations, optimize internal processes […]
What Is Technical Debt? A Complete Overview
Previously published the reasons why some take on debt — intentional or unintentional — on Propelo.AI Small risks can sometimes equal big gains, and many consider technical debt a risk that they are willing to embrace in order to get ahead. But what is technical debt, and how risky can it truly be? At its core, technical debt is a tradeoff that engineering organizations make in order to deliver software on time, or to stay ahead of […]
Startup Wants To Put A Stock Trader In Your Pocket, Aims To Become The Household Name For Algorithmic Trading
DISCLAIMER: During the interview for this story, the creators of PeakBot graciously offered to provide a discount to NewsBreak readers for trying out their services. The author has not received compensation for this article. While a promo code is included at the end of this story, it should not be considered promotional content but rather for informational purposes only. Previously published to NewsBreak. Putting a stock trader in your pocket, one company aims to become […]
Agile Velocity – Good Metric, Use With Caution
The Do’s and Don’ts of Using Velocity in Agile | Previously published to Propelo.AI Agile velocity is a very simple concept that software development teams use to gauge how many tasks can be performed, or completed, on average within a given timeframe. Unfortunately, while it can be extremely useful within the field of project management, it can also be very detrimental if used incorrectly. According to Youtuber Gary Tsang, Your Agile Coach, “Agile velocity is one […]
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for […]